Greystar Europe Holdings has acquired GlaxoSmithKline’s former home in Greenford.
US developer Greystar hope to redevelop the 26.5 acre site as the UK’s largest purpose-built rented housing scheme.
Greystar plan a mixed-use development with significant rental housing content, along with homes for market sale, employment space, retail space, and community use.
